Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Pregnancy
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Pregnancy
    TopAbstracts in Pregnancy 11/03/2009 - (DGNews)
    Study Examines Associations Between Antibiotic Use During Pregnancy, Birth Defects - (DGNews)
    Pregnant Women Show Strong Immune Response to One Dose of H1N1 Vaccine - (DGNews)
    Reliability of self reported smoking status by pregnant women for estimating smoking prevalence: a retrospective, cross sectional study - (BMJ)
    Vaccinated Pregnant Women Protect Their Unborn From Acquiring Seasonal Influenza: Presented at IDSA - (DGDispatch)

    News archive

     Recent webcasts/CME - Pregnancy
    • Improving Epilepsy Management Throughout the Disease Continuum
    • Pregnancy Planning and Preconception Health Care for HIV-Infected Individuals and Couples
      Luteal Support in Reproduction
      Managing the Critically Ill Pregnant Patient
      HIV Testing Update

      Webcasts/CME archive

       Recent cases - Pregnancy
        There May be a Link Between Intrahepatic Cholestasis of Pregnancy and Familial Combined Hyperlipidaemia: A Case Report
        Recurrent Spontaneous Pneumothorax During Pregnancy: A Case Report
        Damage Control Surgery by Keeping the Abdomen Open During Pregnancy: Favorable Outcome, A Case Report
        A Life Threatening Uterine Inversion and Massive Post Partum Hemorrhage Caused by Placenta Accrete During Caesarean Section in a Primigravida: A Case Report
        HELLP Syndrome, Multiple Liver Infarctions, and Intrauterine Fetal Death in a Patient with Systemic Lupus Erythematosus and Antiphospholipid Syndrome

        Cases archive
          




        my personal edition > pregnancy > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Progesterone and Daily Home Uterine Activity Monitoring Prevent Recurrent Preterm Delivery Equally Well: Presented at ACOG

        By Maggie Schwarz

        WASHINGTON, D.C. -- May 11, 2006 -- The two interventions known to prevent preterm delivery work equally well, according to findings presented here at the 54th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists (ACOG).

        Charles Rittenberg, MD, fellow in maternal-fetal medicine, department of obstetrics and gynecology, Medical University of South Carolina, Charleston, South Carolina, reported the findings of his study, which compared the efficacy of home uterine activity monitoring or progesterone injections for prevention of preterm delivery.

        Risks factors for preterm delivery include multiple gestations, previous preterm delivery and cervical incompetence. The two methods commonly used to prevent preterm labor are home uterine activity monitoring and 17-alpha hydroxyprogesterone caproate (17P) injections administered for 16 to 36 weeks.

        For their study, Dr. Rittenberg and colleagues enrolled women with history of preterm delivery and who were receiving outpatient services for home uterine activity monitoring with prenatal nursing assessment or weekly nursing visits with 17P injection. Patients who were receiving 17P were matched 1:1 to patients receiving home uterine activity monitoring by maternal age, marital status, tobacco use, number of preterm deliveries and cerclage of the cervix.

        The primary study outcome was incidence of preterm delivery and data were compared for 305 matched pairs.

        Results show that the incidence of preterm rupture of membranes (8.5% vs. 7.9%, not significant) and preterm labor with preterm delivery at less than 32, 35 and 37 weeks gestation were similar between groups.

        The incidence of hospitalization for suspected preterm labor, use of tocolysis and diagnosis of preterm labor with or without preterm delivery was decreased in patients receiving 17P.

        Dr. Rittenberg stressed that the rate of preterm births is on the rise in the U.S. despite efforts and research aimed to lower it.

        In his presentation on May 9th, Dr. Rittenberg stated, "The 2 methods for reducing preterm delivery work equally well. The next question to answer is whether using both modalities improves outcome even more. That will be our next study."


        [Presentation title: The Incidence of Preterm Labor in Women With Previous Preterm Delivery Treated With 17P-Hydroxyprogesterone Caproate Compared With Home Uterine Activity Monitoring. Abstract p. 37S]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send